Waltham, Mass. — Repligen Corporation (NASDAQ:RGEN) today announced that is has extended a long-term supply agreement with Purolite Life Sciences for the manufacture of Protein A ligands at Repligen’s facilities in Waltham, MA and Lund, Sweden. Repligen is the main strategic supplier of Protein A ligands to Purolite, an emerging player in the Protein A […]
SAN DIEGO — Organovo Holdings, Inc.(NASDAQ:ONVO) (“Organovo”) and Viscient Biosciences (“Viscient”) today announced a collaboration to develop a custom research platform for studying liver disease. The partnership is expected to expand upon Organovo’s current service portfolio for compound screening in disease models, which aids the drug discovery work of the Company’s customers. Viscient is targeting early […]
Collaboration aimed at developing novel “Nephron-on-a-Chip” device to test drug candidates in human kidney: NEPLEX (“NEPHRON-ON-A-CHIP WITH CELLULAR AND EXTRACELLULAR MATRIX COMPLEXITY”) Major step forward to the next generation kidney platform Hamburg, Germany: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced a strategic collaboration on microfluidics technology including induced pluripotent stem cell […]
As of October 2017 Micronit, Axxicon and Helvoet are collaborating in offering a market leading development and manufacturing package to support the growing global demand for high volume polymer microfluidic products. The strong market growth is driven by the new fast diagnostic systems being developed and entering the health care market. At the same time […]
The Institute of Genetics and Molecular and Cellular Biology and Leica Microsystems marked 20 years of collaboration with a day of presentations and scientific talks highlighting the successful projects emerging from the partnership Strasbourg, November 3rd. The longstanding alliance between one of the largest research institutes in France and the pioneering microscopy company was […]
SAN DIEGO — Organovo Holdings, Inc.(NASDAQ:ONVO) (“Organovo”) and Viscient Biosciences (“Viscient”) today announced a collaboration to develop a custom research platform for studying liver disease. The partnership is expected to expand upon Organovo’s current service portfolio for compound screening in disease models, which aids the drug discovery work of the Company’s customers. Viscient is targeting early discovery […]
Consortium will build cloud-based data resources, tools, and interoperable standards, giving researchers simultaneous access to biomedical datasets from across the National Institutes of Health CAMBRIDGE, Mass. – Seven Bridges, the leading biomedical data analysis company, today announced that it has been selected by the National Institutes of Health (NIH) to support the NIH Data Commons Pilot Phase. […]
SHANGHAI, China and CUPERTINO, Calif. — Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a leading clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and effective stem cell therapies for degenerative diseases, today announced the establishment of a strategic partnership with Thermo Fisher Scientific (China) Ltd. (Thermo Fisher) to build a […]
Tokyo, Japan Tokyo based Atonarp Inc., a scientific instrumentation company that designs and manufactures molecular analysis Smart Spectrometer and Buffalo, NY based IMA Life North America (a division of IMA S.p.A., Bologna, Italy) today announced an agreement where Atonarp supplies miniaturized advanced mass spectrometry (AMS) technology to IMA Life, a world leader in the field of aseptic […]
Fluicell AB is extremely pleased to announce the signing of a license agreement with Cellectricon AB, granting the exclusive right, inter alia , to sell the Dynaflow Resolve technology worldwide and to use the related IP rights. The Dynaflow Resolve system is considered by many, to be the premier secondary ion channel screening platform on the market, […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
